RU2021109059A - METHODS OF USE OF A PHENOxyPROPYLAMINE COMPOUND FOR THE TREATMENT OF PAIN - Google Patents
METHODS OF USE OF A PHENOxyPROPYLAMINE COMPOUND FOR THE TREATMENT OF PAIN Download PDFInfo
- Publication number
- RU2021109059A RU2021109059A RU2021109059A RU2021109059A RU2021109059A RU 2021109059 A RU2021109059 A RU 2021109059A RU 2021109059 A RU2021109059 A RU 2021109059A RU 2021109059 A RU2021109059 A RU 2021109059A RU 2021109059 A RU2021109059 A RU 2021109059A
- Authority
- RU
- Russia
- Prior art keywords
- pain
- compound
- subject
- pharmaceutically acceptable
- prodrug
- Prior art date
Links
- 208000002193 Pain Diseases 0.000 title claims 19
- -1 PHENOxyPROPYLAMINE COMPOUND Chemical class 0.000 title claims 3
- 150000001875 compounds Chemical class 0.000 claims 22
- 239000000651 prodrug Substances 0.000 claims 14
- 229940002612 prodrugs Drugs 0.000 claims 14
- 150000003839 salts Chemical class 0.000 claims 14
- 239000011780 sodium chloride Substances 0.000 claims 14
- 239000012453 solvate Substances 0.000 claims 14
- 238000002512 chemotherapy Methods 0.000 claims 8
- 206010029331 Neuropathy peripheral Diseases 0.000 claims 6
- 201000001119 neuropathy Diseases 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 208000001293 Peripheral Nervous System Disease Diseases 0.000 claims 5
- 206010034606 Peripheral neuropathy Diseases 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 5
- 230000002093 peripheral Effects 0.000 claims 5
- 230000001939 inductive effect Effects 0.000 claims 4
- 208000001640 Fibromyalgia Diseases 0.000 claims 2
- RCINICONZNJXQF-MZXODVADSA-N Intaxel Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 2
- 208000010076 Mononeuropathy Diseases 0.000 claims 2
- 208000004296 Neuralgia Diseases 0.000 claims 2
- 229960001592 Paclitaxel Drugs 0.000 claims 2
- 206010036105 Polyneuropathy Diseases 0.000 claims 2
- 208000004358 Polyneuropathy Diseases 0.000 claims 2
- 230000003070 anti-hyperalgesia Effects 0.000 claims 2
- 239000007937 lozenge Substances 0.000 claims 2
- 201000005518 mononeuropathy Diseases 0.000 claims 2
- 230000035945 sensitivity Effects 0.000 claims 2
- 239000007921 spray Substances 0.000 claims 2
- 230000004936 stimulating Effects 0.000 claims 2
- 229930003347 taxol Natural products 0.000 claims 2
- 208000005298 Acute Pain Diseases 0.000 claims 1
- 208000000094 Chronic Pain Diseases 0.000 claims 1
- 208000004454 Hyperalgesia Diseases 0.000 claims 1
- 208000007999 Hyperesthesia Diseases 0.000 claims 1
- 206010065390 Inflammatory pain Diseases 0.000 claims 1
- 229940051866 Mouthwash Drugs 0.000 claims 1
- 208000001294 Nociceptive Pain Diseases 0.000 claims 1
- 208000004550 Postoperative Pain Diseases 0.000 claims 1
- 208000000399 Procedural Pain Diseases 0.000 claims 1
- 208000009935 Visceral Pain Diseases 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 239000006196 drop Substances 0.000 claims 1
- 230000002500 effect on skin Effects 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 150000003840 hydrochlorides Chemical class 0.000 claims 1
- 238000007913 intrathecal administration Methods 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000002324 mouth wash Substances 0.000 claims 1
- 239000002105 nanoparticle Substances 0.000 claims 1
- 239000006072 paste Substances 0.000 claims 1
- 239000000546 pharmaceutic aid Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 239000006188 syrup Substances 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 230000000699 topical Effects 0.000 claims 1
- 230000002588 toxic Effects 0.000 claims 1
- 231100000331 toxic Toxicity 0.000 claims 1
Claims (34)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62/726,800 | 2018-09-04 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2023114062A Division RU2023114062A (en) | 2018-09-04 | 2019-09-04 | METHODS OF USE OF PHENOXYPROPYLAMINE COMPOUND FOR THE TREATMENT OF PAIN |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2021109059A true RU2021109059A (en) | 2022-10-05 |
RU2797615C2 RU2797615C2 (en) | 2023-06-07 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2018133298A (en) | WAYS OF APPLICATION OF FXR AGONISTS | |
JP2009514874A5 (en) | ||
JP2017513824A5 (en) | ||
IL273169B1 (en) | New combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (pf-ild) | |
US8431601B2 (en) | Topical compositions comprising telmesteine for treating dermatological disorders | |
JP2016505050A5 (en) | ||
JP2018531273A5 (en) | ||
KR20090047552A (en) | Pharmaceutical compositions for the treatment of fungal infections | |
MXPA06013830A (en) | Treatment of cancer in pediatric patients. | |
JP2021138703A (en) | Combinations of opioids and n-acylethanolamines | |
RU2017140078A (en) | COSMETIC METHOD AND ITS THERAPEUTIC APPLICATION TO REDUCE THE FATTY OF FAT TISSUE | |
EA201101622A1 (en) | PEPTIDE PHARMACEUTICAL COMPOSITION, MEANS ON ITS BASIS FOR THE TREATMENT OF GASTRODUODENAL DISEASES CAUSED BY HELICOBACTER PYLORI, AND A METHOD OF ITS USE | |
RU2021109059A (en) | METHODS OF USE OF A PHENOxyPROPYLAMINE COMPOUND FOR THE TREATMENT OF PAIN | |
JP2020533402A5 (en) | ||
RU2023114062A (en) | METHODS OF USE OF PHENOXYPROPYLAMINE COMPOUND FOR THE TREATMENT OF PAIN | |
US20210137905A1 (en) | 1-piperidinepropionic acid for treating a fibrosing disease | |
US20050043274A1 (en) | Pharmaceutical compositions and methods for lowering blood pressure and pulse rate | |
GB2591937A (en) | Methods of using a phenoxypropylamine compound to treat pain | |
US6472381B1 (en) | Method of treating psoriasis | |
CN114288289A (en) | Pharmaceutical composition with analgesic and/or antipruritic functions and application thereof | |
RU2721409C1 (en) | Pharmaceutical combinations of histone deacetylase inhibitor and proteasome inhibitor or immunomodulatory drug for treating blood cancer | |
RU2015152175A (en) | COMBINATION RO5503781, CAPETSITABINE AND OXALIPLATIN FOR CANCER THERAPY | |
RU2020108631A (en) | NEW SUPPLEMENTARY THERAPY FOR USE IN THE METHOD OF TREATMENT OF PROSTATE CANCER | |
AU2013301125B2 (en) | A3 adenosine receptor ligands for use in treatment of a sexual dysfunction | |
RU2010150760A (en) | ANTITUMOR AGENT, SET AND METHOD FOR TREATING CANCER |